Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks

Clinical trial NCT00240617 · COMPLETED

Trial details

NCT number: NCT00240617
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine Disorders

Start date: 2005-10-01
Primary completion: 2006-06-01
Enrollment: 623

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.